Announcements Trials
Browse Landscape

Phase

Phase 1 3

Status

Recruiting 62Active not recruiting 50Not yet recruiting 14Completed 13Terminated 12Withdrawn 7Suspended 4Enrolling by invitation 3Unknown 2

Sponsor Class

NIH 3OTHER 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 8Lymphoid 5Genitourinary 5Gastrointestinal 4Sarcoma 3Myeloid 3CNS 3Breast 3Tumor-Agnostic 2Dermatologic 2Thoracic 1Plasma cell 1Other solid neoplasm 1Head & Neck 1Gynecologic 1Classical hematology 1

Conditions

Carcinoma, Hepatocellular 2Prostatic Neoplasms 1Pancreatic Neoplasms 1Multiple Myeloma 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Renal Cell 1Breast Neoplasms 1

Interventions

Gemcitabine 6Oxaliplatin 5Irinotecan 5Specimen Handling 4S 1 (combination) 4Leucovorin 4Fluorouracil 4Capecitabine 4Radiotherapy 3Nivolumab 3Drug Therapy 3Bevacizumab 3trifluridine tipiracil drug combination 2titanium silicide 2spartalizumab 2lenvatinib 2aldesleukin 2Surgical Procedures, Operative 2Photochemotherapy 2Magnetic Resonance Spectroscopy 2Interleukin-2 2Immunotherapy 2Endoscopic Mucosal Resection 2Cyclophosphamide 2Cetuximab 2Biopsy 2Albumin-Bound Paclitaxel 2130-nm albumin-bound paclitaxel 2zimberelimab 1vactosertib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Suspended × Specimen Handling × Gastrointestinal × Clear all
NCT05685602 2026-05-18

CA-4948 Added to Standard Chemotherapy to Treat Metastatic or Unresectable Pancreatic Cancer

National Cancer Institute (NCI)

Phase 1 Suspended
43 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT04955808 2026-05-13

Biospecimen Collection in Identifying Genetic Changes in Patients With Breast, Prostate, Colorectal, Liver, or Kidney Cancer or Multiple Myeloma Undergoing Surgery

National Cancer Institute (NCI)

Suspended
2,400 enrolled
BreastGastrointestinalGenitourinaryPlasma cell

Breast Neoplasms, Carcinoma, Renal Cell, Colonic Neoplasms, Carcinoma, Hepatocellular, Multiple Myeloma, Prostatic Neoplasms

NCT06102902 2026-05-13

Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer

National Cancer Institute (NCI)

Phase 1 Suspended
30 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT06968195 2026-04-15

Autologous CAR T Cells Targeting GPC3 (RPCAR01) for the Treatment of Advanced or Metastatic GPC3 Expressing Hepatocellular Carcinoma

Roswell Park Cancer Institute

Phase 1 Suspended
24 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡